Under physiological conditions, CD8+ activation occurs in secondary lymphoid organs, such as lymph nodes, but it can also occur in organized tertiary lymphoid structures within the tumor [52], where the antitumor immune response can be orchestrated [53]. The gene discussed is CD8A; the disease is neoplasm.